(Q46630907)

English

Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia

scientific article published on 22 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

1 reference

based on heuristic

inferred from title

John J. P. Kastelein

2

object named as

John J P Kastelein

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

author name string

Menno Vergeer

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

publication date

22 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

Nature Clinical Practice Cardiovascular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

302-303

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1190

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1190

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1190

7 January 2021

based on heuristic

inferred from DOI database lookup

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1190

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NCPCARDIO1190

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18431368

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46630907&oldid=2123111410"